Effect of Lifestyle Intervention Among Patients With Hypertension or High-normal Blood Pressure (NCT05528068) | Clinical Trial Compass
UnknownNot Applicable
Effect of Lifestyle Intervention Among Patients With Hypertension or High-normal Blood Pressure
China424 participantsStarted 2022-07-27
Plain-language summary
Hypertension is a major risk factor for cardiovascular disease and cardiovascular events. Healthy lifestyle factors are widely recommended for hypertension prevention and control, and cardiorespiratory fitness is a strong and independent predictor of the progression of hypertension. Increased cardiorespiratory fitness through lifestyle modifications is associated with lower mortality in hypertensive or high-normal blood pressure individuals. The aim of the study is to evaluate the effects of supervised lifestyle intervention that include diet and exercise and base on intelligent application and continuous physiological monitoring on improvement of cardiopulmonary fitness, blood pressure and other health outcomes among participants with hypertension or high-normal blood pressure.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. who is ≥18 years old and \< 70 years old;
✓. hypertension or high-normal blood pressure;
✓. who has a smart phone and can use it (android phones are preferred).
Exclusion criteria
✕. with acute myocardial infarction, acute tachyarrhythmia, pulmonary edema, severe aortic stenosis and other serious circulatory diseases or respiratory diseases;
✕. with acute cardiovascular and cerebrovascular diseases;
✕. poor blood pressure control;
✕. with physical limitations(e.g., restricting injuries of the musculoskeletal system, such as fractures, unstable joints and other physical diseases);
✕. with skin disease or skin damage at the site of wearable device;
✕. with mental disorder, epilepsy or other diseases resulting in inability to control the body;
✕
What they're measuring
1
Change in peak oxygen uptake (VO2peak) from baseline to 3 months
Timeframe: baseline, 3 months
Trial details
NCT IDNCT05528068
SponsorChina National Center for Cardiovascular Diseases